• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Materialise Reports Second Quarter 2025 Results

    7/24/25 6:30:00 AM ET
    $MTLS
    Computer Software: Prepackaged Software
    Technology
    Get the next $MTLS alert in real time by email

    Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the second quarter ended June 30, 2025.

    Highlights – Second Quarter 2025

    • Total consolidated revenue decreased 5.8% to 64,831 kEUR compared to the corresponding 2024 period; however at the same time our Materialise Medical segment showed a further 16.7% growth.
    • Gross profit as a percentage of revenue for the second quarter of 2025 increased to 58.3%, compared to 57.0% for the corresponding 2024 period.
    • Adjusted EBIT improved to 3,058 kEUR for the second quarter of 2025 from 646 kEUR for the first quarter of 2025, although it remained below the 3,872 kEUR of the corresponding 2024 period.
    • Net result for the second quarter remained positive at 199 kEUR, or 0.0 EUR per diluted share, despite a significant impact from unfavorable exchange rate fluctuations.
    • Driven by positive free cash flow during the first half of 2025, our reported net cash position increased by 2,025 kEUR to 63,045 kEUR compared to December 31, 2024.

    CEO Brigitte de Vet-Veithen commented, "Our Materialise Medical segment once again demonstrated its resilience, growing by almost 17% compared to the same period of 2024. At the same time increasing geo-political uncertainty and sustained macro-economic headwinds negatively impacted revenues in our Materialise Manufacturing and Materialise Software segments, and therefore also our consolidated revenue in the second quarter of 2025. Despite revenue pressure we were able to materially improve our operational profitability in Q2 2025 compared to prior periods through structural and targeted cost control. Unfavorable effects from exchange rate fluctuations significantly impacted our quarterly financials, but we nevertheless again reported a positive net result."

    Second Quarter 2025 Results

    Total revenue for the second quarter of 2025 decreased 5.8% to 64,831 kEUR from 68,797 kEUR for the second quarter of 2024. Adjusted EBIT was 3,058 kEUR for the second quarter of 2025 compared to 3,872 kEUR for the 2024 period. The Adjusted EBIT margin (Adjusted EBIT divided by total revenue) for the second quarter of 2025 was 4.7%, compared to 5.6% for the second quarter of 2024. Adjusted EBITDA for the second quarter of 2025 was 8,288 kEUR compared to 9,188 kEUR for the 2024 period.

    Revenue from our Materialise Medical segment increased 16.7% to 32,850 kEUR for the second quarter of 2025 compared to 28,141 kEUR for the same period in 2024. Segment Adjusted EBITDA amounted to 10,728 kEUR for the second quarter of 2025 compared to 8,199 kEUR, while the segment Adjusted EBITDA margin was 32.7% compared to 29.1% for the second quarter of 2024.

    Revenue from our Materialise Software segment decreased 12.1% to 9,872 kEUR for the second quarter of 2025 from 11,226 kEUR for the same quarter last year. Segment Adjusted EBITDA remained stable at 1,373 kEUR from 1,374 kEUR, while the segment Adjusted EBITDA margin was 13.9% compared to 12.2% for the corresponding prior-year period, reflecting the impact of strict cost control.

    Revenue from our Materialise Manufacturing segment decreased 24.9% to 22,109 kEUR for the second quarter of 2025 from 29,429 kEUR for the second quarter of 2024. Segment Adjusted EBITDA amounted to (807) kEUR compared to 2,416 kEUR for the same period in 2024, while the segment Adjusted EBITDA margin was (3.6)% compared to 8.2% for the second quarter of 2024.

    Gross profit was 37,778 kEUR for the second quarter of 2025 compared to 39,227 kEUR for the same period last year, while gross profit as a percentage of revenue increased to 58.3% compared to 57.0% for the second quarter of 2024.

    Research and development ("R&D"), sales and marketing ("S&M"), and general and administrative ("G&A") expenses decreased, in the aggregate, by 0.8% to 36,334 kEUR for the second quarter of 2025 from 36,631 kEUR for the second quarter of 2024.

    Net other operating income was 1,286 kEUR compared to 1,205 kEUR for the second quarter of 2024.

    Operating result amounted to 2,730 kEUR compared to 3,801 kEUR for the second quarter of 2024.

    Net financial result was (3,052) kEUR compared to 1,033 kEUR for the second quarter of 2024, reflecting highly unfavorable effects from unrealized exchange rate fluctuations.

    The second quarter of 2025 contained income tax benefits of 521 kEUR, compared to income tax expenses of (959) kEUR in the second quarter of 2024.

    As a result of the above, net profit for the second quarter of 2025 was 199 kEUR, compared to 3,875 kEUR for the same period in 2024. Total comprehensive income for the second quarter of 2025, which includes exchange differences on translation of foreign operations, was 823 kEUR compared to 3,093 kEUR for the corresponding 2024 period.

    At June 30, 2025, we report 116,712 kEUR cash and cash equivalents on our balance sheet compared to 102,304 kEUR at December 31, 2024. Gross debt amounted to 53,667 kEUR, compared to 41,284 kEUR at December 31, 2024. As a result, our reported net cash position was 63,045 kEUR, an increase of 2,025 kEUR compared to December 31, 2024.

    Cash flow from operating activities for the second quarter of 2025 was (27) kEUR compared to 8,400 kEUR for the same period in 2024. Total cash out from capital expenditures for the second quarter of 2025 amounted to 4,729 kEUR.

    Net shareholders' equity at June 30, 2025 was 249,488 kEUR compared to 248,578 kEUR at December 31, 2024.

    2025 Guidance

    Mrs. de Vet-Veithen concluded, "As we move through 2025 we see a risk that geo-political volatility and macro-economic uncertainty intensify and also impact the business climate for the remainder of this year. Unfavorable foreign exchange fluctuations might also add to the pressure on our revenue line and reported net result. We therefore believe it is prudent to slightly reduce our revenue guidance for the full fiscal year to a range of 265,000 to 280,000 kEUR. We remain convinced though that the fundamentals of our business are solid and resilient and believe that further structural cost efficiencies will allow us to safeguard operational profitability. Despite the slightly lower revenue outlook we are therefore reconfirming our Adjusted EBIT guidance of 6,000 kEUR to 10,000 kEUR for fiscal year 2025 in line with our earlier communications in February and April of this year."

    Non-IFRS Measures

    Materialise uses EBIT, EBITDA, Adjusted EBIT and Adjusted EBITDA as supplemental financial measures of its financial performance. EBIT is calculated as net profit plus income taxes, financial expenses (less financial income) and shares of profit or loss in a joint venture. EBITDA is calculated as net profit plus income taxes, financial expenses (less financial income), shares of profit or loss in a joint venture and depreciation and amortization. Adjusted EBIT and Adjusted EBITDA are determined by adding to EBIT and EBITDA, respectively (i) share-based compensation expenses, (ii) acquisition or divestiture-related expenses of business combinations, (iii) impairments and revaluation of fair value due to business combinations and (iv) costs incurred in relation to corporate initiatives, restructurings or reorganizations that are of a non-recurring nature. Management believes these non-IFRS measures to be important measures as they exclude the effects of items which primarily reflect the impact of financing decisions and, in the case of EBITDA and Adjusted EBITDA, long term investment, rather than the performance of the company's day-to-day operations. The company also uses segment Adjusted EBITDA to evaluate the performance of its three business segments. As compared to net profit, these measures are limited in that they do not reflect the cash requirements necessary to service interest or principal payments on the company's indebtedness and, in the case of EBITDA and Adjusted EBITDA, these measures are further limited in that they do not reflect the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in the company's business, or the changes associated with impairments. Management evaluates such items through other financial measures such as financial expenses, capital expenditures and cash flow provided by operating activities. The company believes that these measurements are useful to measure a company's ability to grow or as a valuation measurement. The company's calculation of EBIT, EBITDA, Adjusted EBIT and Adjusted EBITDA may not be comparable to similarly titled measures reported by other companies. EBIT, EBITDA, Adjusted EBIT and Adjusted EBITDA should not be considered as alternatives to net profit or any other performance measure derived in accordance with IFRS. The company's presentation of EBIT, EBITDA, Adjusted EBIT and Adjusted EBITDA should not be construed to imply that its future results will be unaffected by unusual or non-recurring items.

    Exchange Rate

    This document contains translations of certain euro amounts into U.S. dollars at specified rates solely for the convenience of readers. Unless otherwise noted, all translations from euros to U.S. dollars in this document were made at a rate of EUR 1.00 to USD 1.1720, the reference rate of the European Central Bank on June 30, 2025.

    Conference Call and Webcast

    Materialise will hold a conference call and simultaneous webcast to discuss its financial results for the second quarter of 2025 on Thursday, July 24, 2025, at 8:30 a.m. ET/2:30 p.m. CET. Company participants on the call will include Brigitte de Vet-Veithen, Chief Executive Officer and Koen Berges, Chief Financial Officer. A question-and-answer session will follow management's remarks.

    To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's conference call.

    • https://register-conf.media-server.com/register/BIcf55b247aa2d4dfc819bfe1b5959cb67

    The conference call will also be broadcast live over the Internet with an accompanying slide presentation, which can be accessed on the company's website at http://investors.materialise.com. The webcast of the conference call will be archived on the company's website for one year.

    About Materialise

    Materialise NV incorporates more than three decades of 3D printing experience into a range of software solutions and 3D printing services that empower sustainable 3D printing applications. Our open, secure, and innovative end-to-end solutions enable flexible industrial manufacturing and mass personalization in various industries — including healthcare, automotive, aerospace, eyewear, art and design, wearables, and consumer goods. Headquartered in Belgium and with branches worldwide, Materialise NV combines the largest group of software developers in the industry with one of the world's largest and most complete 3D printing facilities. For additional information, please visit: www.materialise.com.

    Cautionary Statement on Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prospects, both financial and business, including statements concerning, among other things, our estimates for the current fiscal year's revenue and Adjusted EBIT, our results of operations, cash needs, capital expenditures, expenses, financial condition, liquidity, prospects, growth and strategies (including how our business, results of operations and financial condition could be impacted by the current armed geopolitical conflicts around the world and governmental responses thereto, inflation, increased labor, energy and materials costs), policy changes resulting from the U.S. presidential administration, changes in tariffs and trade restrictions, and the trends and competition that may affect the markets, industry or us. Such statements are subject to known and unknown uncertainties and risks. When used in this press release, the words "estimate," "expect," "anticipate," "project," "plan," "intend," "believe," "forecast," "will," "may," "could," "might," "aim," "should," and variations of such words or similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon the expectations of management under current assumptions at the time of this press release. These expectations, beliefs and projections are expressed in good faith and the company believes there is a reasonable basis for them. However, the company cannot offer any assurance that our expectations, beliefs and projections will actually be achieved. By their nature, forward-looking statements involve risks and uncertainties because they relate to events, competitive dynamics and industry change, and depend on economic circumstances that may or may not occur in the future or may occur on longer or shorter timelines than anticipated. We caution you that forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that are in some cases beyond our control. All of the forward-looking statements are subject to risks and uncertainties that may cause the company's actual results to differ materially from our expectations, including risk factors described in the company's most recent annual report on Form 20-F filed with the U.S. Securities and Exchange Commission. There are a number of risks and uncertainties that could cause the company's actual results to differ materially from the forward-looking statements contained in this press release.

    The company is providing this information as of the date of this press release and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise, unless it has obligations under the federal securities laws to update and disclose material developments related to previously disclosed information.

    Consolidated income statements (Unaudited)

    for the three months ended

    June 30,
    for the six months ended

    June 30,
    In '000

    2025

     

    2025

     

    2024

     

    2025

     

    2024

    U.S.$ € € € €
    Revenue

    75,982

    64,831

    68,797

    131,210

    132,434

    Cost of Sales

    (31,707)

    (27,053)

    (29,570)

    (56,708)

    (57,270)

    Gross Profit

    44,276

    37,778

    39,227

    74,502

    75,164

    Gross profit as % of revenue

    58.3%

    58.3%

    57.0%

    56.8%

    56.8%

     
    Research and development expenses

    (13,032)

    (11,120)

    (11,090)

    (22,534)

    (21,322)

    Sales and marketing expenses

    (18,132)

    (15,471)

    (15,636)

    (30,542)

    (30,234)

    General and administrative expenses

    (11,420)

    (9,744)

    (9,905)

    (19,769)

    (19,214)

    Net other operating income (expenses)

    1,508

    1,286

    1,205

    1,646

    1,994

    Operating (loss) profit

    3,200

    2,730

    3,801

    3,303

    6,387

     
    Financial expenses

    (4,733)

    (4,039)

    (1,441)

    (6,811)

    (2,239)

    Financial income

    1,157

    987

    2,474

    2,884

    4,783

    (Loss) profit before taxes

    (376)

    (322)

    4,834

    (624)

    8,930

     
    Income Taxes

    610

    521

    (959)

    287

    (1,469)

    Net (loss) profit for the period

    234

    199

    3,875

    (337)

    7,461

    Net (loss) profit attributable to:
    The owners of the parent

    233

    199

    3,882

    (336)

    7,474

    Non-controlling interest

    -

    -

    (7)

    (2)

    (13)

     
    Earning per share attributable to owners of the parent
    Basic

    0.00

    0.00

    0.07

    (0.01)

    0.13

    Diluted

    0.00

    0.00

    0.07

    (0.01)

    0.13

     
    Weighted average basic shares outstanding

    59,067

    59,067

    59,067

    59,067

    59,067

    Weighted average diluted shares outstanding

    59,067

    59,067

    59,067

    59,067

    59,077

    Consolidated statements of comprehensive income (Unaudited)

    for the three months ended

    June 30,
    for the six months ended

    June 30,
    In 000€

    2025

     

    2025

     

    2024

     

    2025

     

    2024

    U.S.$ € € € €
    Net profit (loss) for the period

    234

    199

    3,875

    (337)

    7,461

    Other comprehensive income
    Recycling
    Exchange difference on translation of foreign operations

    731

    624

    (783)

    1,129

    (1,056)

    Non-recycling
    Fair value adjustments through OCI - Equity instruments

    -

    -

    -

    -

    -

    Other comprehensive income (loss), net of taxes

    731

    624

    (783)

    1,129

    (1,056)

    Total comprehensive income (loss) for the year, net of taxes

    964

    823

    3,093

    792

    6,406

    Total comprehensive income (loss) attributable to:
    The owners of the parent

    958

    817

    3,100

    785

    6,419

    Non-controlling interests

    6

    6

    (7)

    7

    (14)

    Consolidated statement of financial position (Unaudited)

    As of

    June 30,
    As of

    December 31,
    In 000€

    2025

    2024

    Assets
    Non-current assets
    Goodwill

    43,249

    43,391

    Intangible assets

    27,751

    29,973

    Property, plant & equipment

    111,225

    111,331

    Right-of-Use assets

    6,920

    7,719

    Deferred tax assets

    3,761

    3,523

    Investments in convertible loans

    4,118

    3,994

    Other non-current assets

    5,707

    5,893

    Total non-current assets

    202,729

    205,823

    Current assets
    Inventories

    14,678

    16,992

    Trade receivables

    49,564

    53,052

    Other current assets

    16,197

    18,166

    Cash and cash equivalents

    116,712

    102,304

    Assets held for sale

    4,504

    -

    Total current assets

    201,656

    190,513

    Total assets

    404,385

    396,336

    As of

    June 30,
    As of

    December 31,
    In 000€

    2025

    2024

    Equity and liabilities
    Equity
    Share capital

    4,487

    4,487

    Share premium

    233,895

    233,895

    Retained earnings and other reserves

    11,106

    10,196

    Equity attributable to the owners of the parent

    249,488

    248,578

    Non-controlling interest

    (78)

    (86)

    Total equity

    249,410

    248,492

    Non-current liabilities
    Loans & borrowings

    38,388

    23,175

    Lease liabilities

    4,641

    5,112

    Deferred tax liabilities

    2,923

    3,202

    Deferred income

    15,343

    13,268

    Other non-current liabilities

    326

    910

    Total non-current liabilities

    61,621

    45,666

    Current liabilities
    Loans & borrowings

    8,151

    10,383

    Lease liabilities

    2,487

    2,614

    Trade payables

    20,091

    23,348

    Tax payables

    560

    1,432

    Deferred income

    45,070

    45,998

    Other current liabilities

    16,049

    18,403

    Liabilities held for sale

    944

    -

    Total current liabilities

    93,354

    102,178

    Total equity and liabilities

    404,385

    396,336

    Consolidated statement of cash flows (Unaudited)

    for the six months ended

    June 30,
    In 000€

    2025

    2024

    Operating activities
    Net (loss) profit for the period

    (337)

    7,461

    Non-cash and operational adjustments

    14,087

    10,203

    Depreciation of property plant & equipment

    7,448

    7,539

    Amortization of intangible assets

    3,210

    3,204

    Share-based payment expense

    117

    142

    Loss (gain) on disposal of intangible assets and property, plant & equipment

    (21)

    (77)

    Government grants

    (101)

    -

    Movement in provisions

    (366)

    191

    Movement reserve for bad debt and slow moving inventory

    271

    272

    Financial income

    (2,876)

    (4,762)

    Financial expense

    6,770

    2,241

    Impact of foreign currencies

    (70)

    (10)

    (Deferred) income taxes

    (295)

    1,462

    Working capital adjustments

    (4,684)

    (574)

    Decrease (increase) in trade receivables and other receivables

    2,093

    3,134

    Decrease (increase) in inventories and contracts in progress

    (500)

    (1,029)

    Increase (decrease) in deferred revenue

    (264)

    (1,768)

    Increase (decrease) in trade payables and other payables

    (6,014)

    (911)

    Income tax paid & Interest received

    620

    1,280

    Net cash flow from operating activities

    9,686

    18,370

    for the six months ended

    June 30,
    In 000€

    2025

    2024

    Investing activities
    Purchase of property, plant & equipment

    (5,617)

    (10,475)

    Purchase of intangible assets

    (944)

    (814)

    Proceeds from the sale of property, plant & equipment & intangible assets (net)

    233

    185

    Capital government grants received

    2,640

    -

    Net cash flow used in investing activities

    (3,688)

    (11,104)

    Financing activities
    Proceeds from loans & borrowings

    20,000

    -

    Repayment of loans & borrowings

    (6,860)

    (6,841)

    Repayment of leases

    (1,544)

    (1,517)

    Capital increase

    -

    -

    Interest paid

    (621)

    (800)

    Other financial income (expense)

    (1,300)

    169

    Net cash flow from (used in) financing activities

    9,676

    (8,989)

    Net increase/(decrease) of cash & cash equivalents

    15,673

    (1,723)

    Cash & Cash equivalents at the beginning of the year

    102,304

    127,573

    Exchange rate differences on cash & cash equivalents

    (913)

    (358)

    Cash & cash equivalents at end of the period

    117,064

    125,492

    Reconciliation of Net Profit (Loss) to EBITDA and Adjusted EBITDA (Unaudited)

    for the three months ended

    June 30,
    for the six months ended

    June 30,
    In 000€

    2025

    2024

    2025

    2024

    Net profit (loss) for the period

    199

    3,875

    (337)

    7,461

    Income taxes

    (521)

    959

    (287)

    1,469

    Financial expenses

    4,039

    1,441

    6,811

    2,239

    Financial income

    (987)

    (2,474)

    (2,884)

    (4,783)

    Depreciation and amortization

    5,230

    5,316

    10,731

    10,754

    EBITDA

    7,960

    9,117

    14,034

    17,141

    Share-based compensation expense (1)

    45

    71

    117

    142

    Restructuring and corporate initiatives (2)

    283

    -

    283

    -

    Adjusted EBITDA

    8,288

    9,188

    14,434

    17,283

     
    (1) Share-based compensation expense represents the cost of equity-settled and share-based payments to employees.
    (2) Non-recurring costs related to corporate initiatives, restructurings or reorganizations.
     

    Reconciliation of Net Profit (Loss) to EBIT and Adjusted EBIT (Unaudited)

    for the three months ended

    June 30,
    for the six months ended

    June 30,
    In 000€

    2025

    2024

    2025

    2024

    Net profit (loss) for the period

    199

    3,875

    (337)

    7,461

    Income taxes

    (521)

    959

    (287)

    1,469

    Financial expenses

    4,039

    1,441

    6,811

    2,239

    Financial income

    (987)

    (2,474)

    (2,884)

    (4,783)

    EBIT

    2,730

    3,801

    3,303

    6,387

    Share-based compensation expense (1)

    45

    71

    117

    142

    Restructuring and corporate initiatives (2)

    283

    -

    283

    -

    Adjusted EBIT

    3,058

    3,872

    3,703

    6,529

     
    (1) Share-based compensation expense represents the cost of equity-settled and share-based payments to employees.
    (2) Non-recurring costs related to corporate initiatives, restructurings or reorganizations.

    Segment P&L (Unaudited)

    In 000€ Materialise

    Medical
    Materialise

    Software
    Materialise

    Manufacturing
    Total

    segments
    Unallocated

    (1)
    Consolidated
    For the three months ended June 30, 2025
    Revenues

    32,850

    9,872

    22,109

    64,831

    (0)

    64,831

    Segment (adj) EBITDA

    10,728

    1,373

    (807)

    11,294

    (3,005)

    8,288

    Segment (adj) EBITDA %

    32.7%

    13.9%

    -3.6%

    17.4%

    12.8%

    For the three months ended June 30, 2024
    Revenues

    28,141

    11,226

    29,429

    68,797

    0

    68,797

    Segment (adj) EBITDA

    8,199

    1,374

    2,416

    11,990

    (2,802)

    9,188

    Segment (adj) EBITDA %

    29.1%

    12.2%

    8.2%

    17.4%

    13.4%

     
    In 000€ Materialise

    Medical
    Materialise

    Software
    Materialise

    Manufacturing
    Total

    segments
    Unallocated

    (1)
    Consolidated
    For the six months ended June 30, 2025
    Revenues

    63,928

    19,647

    47,635

    131,210

    (0)

    131,210

    Segment (adj) EBITDA

    19,775

    1,971

    (1,185)

    20,561

    (6,127)

    14,434

    Segment (adj) EBITDA %

    30.9%

    10.0%

    -2.5%

    15.7%

    11.0%

    For the six months ended June 30, 2024
    Revenues

    54,324

    21,665

    56,445

    132,434

    0

    132,434

    Segment (adj) EBITDA

    16,120

    2,464

    3,947

    22,531

    (5,248)

    17,283

    Segment (adj) EBITDA %

    29.7%

    11.4%

    7.0%

    17.0%

    13.1%

    (1) Unallocated segment adjusted EBITDA consists of corporate research and development and corporate other operating income (expense), and the added share-based compensation expenses, acquisition or divestiture-related expenses of business combinations, impairments and revaluation of fair value of business combinations and non-recurring costs related to corporate initiatives, restructurings and reorganizations that are included in Adjusted EBITDA and that are not allocated to the reporting segments.

    Reconciliation of Net Profit (Loss) to Segment adjusted EBITDA (Unaudited)

    for the three months ended

    June 30,
    for the six months ended

    June 30,
    In 000€

    2025

    2024

    2025

    2024

    Net profit (loss) for the period

    199

    3,875

    (337)

    7,461

    Income taxes

    (521)

    959

    (287)

    1,469

    Financial cost

    4,039

    1,441

    6,811

    2,239

    Financial income

    (987)

    (2,474)

    (2,884)

    (4,783)

    Operating (loss) profit

    2,730

    3,801

    3,303

    6,387

    Depreciation and amortization

    5,230

    5,316

    10,731

    10,754

    Corporate research and development

    1,070

    955

    2,100

    1,763

    Corporate headquarter costs

    2,895

    2,601

    5,747

    5,083

    Other operating income (expense)

    (810)

    (682)

    (1,498)

    (1,456)

    Segment restructuring and reorganization

    178

    -

    178

    -

    Segment adjusted EBITDA

    11,294

    11,990

    20,561

    22,531

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250724310211/en/

    Investor Relations:

    Harriet Fried

    Alliance Advisors Investor Relations

    212.838.3777

    [email protected]

    Get the next $MTLS alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MTLS

    DatePrice TargetRatingAnalyst
    4/24/2024$9.50Overweight
    Cantor Fitzgerald
    5/26/2023$11.00Hold → Buy
    Kepler
    3/25/2022$20.00Buy → Neutral
    Bryan Garnier
    10/20/2021$28.00Overweight
    JP Morgan
    9/2/2021$30.00Buy
    Stifel
    8/9/2021$30.00Buy
    Lake Street
    More analyst ratings

    $MTLS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald initiated coverage on Materialise with a new price target

      Cantor Fitzgerald initiated coverage of Materialise with a rating of Overweight and set a new price target of $9.50

      4/24/24 6:23:39 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise upgraded by Kepler with a new price target

      Kepler upgraded Materialise from Hold to Buy and set a new price target of $11.00

      5/26/23 7:40:13 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise downgraded by Bryan Garnier with a new price target

      Bryan Garnier downgraded Materialise from Buy to Neutral and set a new price target of $20.00

      3/25/22 9:23:58 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Materialise Reports Second Quarter 2025 Results

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the second quarter ended June 30, 2025. Highlights – Second Quarter 2025 Total consolidated revenue decreased 5.8% to 64,831 kEUR compared to the corresponding 2024 period; however at the same time our Materialise Medical segment showed a further 16.7% growth. Gross profit as a percentage of revenue for the second quarter of 2025 increased to 58.3%, compared to 57.0% for the corresponding 2024 period. Adjusted EBIT improved to 3,058 kEUR for the second quarter of 2025 from 646 kEUR for the first quarte

      7/24/25 6:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise NV to Report Second Quarter 2025 Earnings on Thursday, July 24, 2025

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the second quarter ended June 30, 2025 on Thursday, July 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the second quarter 2025 financial results on Thursday, July 24, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's conference call:

      7/10/25 10:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise to Hold Annual Shareholders' Meeting and Extraordinary Shareholders' Meeting on June 3, 2025

      LEUVEN, Belgium, May 16, 2025 (GLOBE NEWSWIRE) -- Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and sophisticated 3D printing solutions, today announced that it will host its Annual General Shareholders' Meeting (AGM) on Tuesday, June 3, 2025, at 10:00 am CET. On the same date, Materialise will convene an Extraordinary Shareholders' Meeting to discuss and vote on proposals to amend its articles of association (to renew the authorization of the Board of Directors to increase Materialise's authorized share capital, and to move the statutory date of the AGM starting in 2026). The convening notices and other documents pertaining to the Annual General S

      5/16/25 5:59:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    SEC Filings

    See more
    • SEC Form 6-K filed by Materialise NV

      6-K - MATERIALISE NV (0001091223) (Filer)

      7/24/25 6:41:38 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 6-K filed by Materialise NV

      6-K - MATERIALISE NV (0001091223) (Filer)

      7/24/25 6:39:59 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 6-K filed by Materialise NV

      6-K - MATERIALISE NV (0001091223) (Filer)

      6/12/25 4:52:05 PM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    Leadership Updates

    Live Leadership Updates

    See more
    • 3D Printing Pioneer Materialise Appoints Brigitte de Vet-Veithen as New CEO

      Fried Vancraen, Co-founder and CEO, to become Chairman of the Board Materialise NV (NASDAQ:MTLS), a global leader in 3D printing software and services, today announced that the company's Board of Directors has appointed Brigitte de Vet-Veithen as Chief Executive Officer. Brigitte de Vet-Veithen will succeed Fried Vancraen, who co-founded Materialise in 1990 and has served as the company's CEO for 33 years. Mr. Vancraen will continue to represent Materialise as the new Chairman of the Board of Directors. The leadership transition will become effective on January 1, 2024, as part of the management changes described below. "We founded Materialise with a mission to create a better and healt

      10/26/23 3:00:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    Financials

    Live finance-specific insights

    See more
    • Materialise Reports Second Quarter 2025 Results

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the second quarter ended June 30, 2025. Highlights – Second Quarter 2025 Total consolidated revenue decreased 5.8% to 64,831 kEUR compared to the corresponding 2024 period; however at the same time our Materialise Medical segment showed a further 16.7% growth. Gross profit as a percentage of revenue for the second quarter of 2025 increased to 58.3%, compared to 57.0% for the corresponding 2024 period. Adjusted EBIT improved to 3,058 kEUR for the second quarter of 2025 from 646 kEUR for the first quarte

      7/24/25 6:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise NV to Report Second Quarter 2025 Earnings on Thursday, July 24, 2025

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing software and of sophisticated 3D printing services, today announced that it will release financial results for the second quarter ended June 30, 2025 on Thursday, July 24, 2025 at 6:30 a.m. ET/12:30 p.m. CET. Senior management will hold a conference call to discuss the second quarter 2025 financial results on Thursday, July 24, 2025 at 8:30 a.m. ET/2:30 p.m. CET. To access the call by phone, please click the link below at least 15 minutes prior to the scheduled start time and you will be provided with dial-in details. Participants can choose to dial in or receive a call to connect to Materialise's conference call:

      7/10/25 10:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • Materialise Reports First Quarter 2025 Results

      Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its financial results for the first quarter ended March 31, 2025. Highlights – First Quarter 2025 Boosted by 18.7% growth in our Materialise Medical segment, total revenue increased by 4.3% to 66,379 kEUR for the first quarter of 2025 compared to the corresponding 2024 period. Total deferred revenues from software maintenance and license fees increased during the quarter by 1,921 kEUR, to 48,870 kEUR. Adjusted EBIT improved to 646 kEUR for the first quarter of 2025 from (1,195) kEUR for the fourth quarter of 2024, but remained belo

      4/24/25 6:30:00 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology

    $MTLS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Materialise NV (Amendment)

      SC 13G/A - MATERIALISE NV (0001091223) (Subject)

      2/10/23 1:44:50 PM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Materialise NV (Amendment)

      SC 13G/A - MATERIALISE NV (0001091223) (Subject)

      2/14/22 6:05:34 AM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Materialise NV (Amendment)

      SC 13G/A - MATERIALISE NV (0001091223) (Subject)

      2/9/22 2:44:00 PM ET
      $MTLS
      Computer Software: Prepackaged Software
      Technology